Sant Chawla, Inc.

Clinical research site in Santa Monica, California · 2811 WILSHIRE BLVD. SUITE #414, SANTA MONICA, CA 90403 · (310) 552-9999

As of July 2026, 17 paid clinical trials are recruiting at Sant Chawla, Inc. in Santa Monica, California. Active studies at this site cover conditions such as Leiomyosarcoma, Sarcoma and Solid Tumor. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Sant Chawla, Inc. (17)

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

for Non-small Cell Lung Cancer

28 locations incl. Fresno

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT07195695·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

FOG-001 in Locally Advanced or Metastatic Solid Tumors

for Cancer

30 locations incl. Phoenix

Sponsor: Parabilis Medicines, Inc.

Sex: All·Age: 18+

Code: NCT05919264·Phase 1, Phase 2·Recruiting·Listed Jun 2023

Apply to this trial

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

for Ewing Sarcoma

18 locations incl. Beverly Hills

Sponsor: Inhibrx Biosciences, Inc

Sex: All·Age: 12 - 85

Code: NCT03715933·Phase 1·Recruiting·Listed Oct 2018

Apply to this trial

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

for Advanced Solid Tumors

11 locations incl. San Diego

Sponsor: Pyxis Oncology, Inc

Sex: All·Age: 18+

Code: NCT06795412·Phase 1, Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

for Alveolar Soft Part Sarcoma

1 location in Santa Monica

Sponsor: Advenchen Laboratories, LLC

Sex: All·Age: 18+

Code: NCT03016819·Phase 3·Recruiting·Listed Jan 2017

Apply to this trial

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

for Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen

22 locations incl. Los Angeles

Sponsor: Servier Bio-Innovation LLC

Sex: All·Age: 18+

Code: NCT06127407·Phase 3·Recruiting·Listed Nov 2023

Apply to this trial

Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors

for Solid Tumor

11 locations incl. Gilbert

Sponsor: ImmunoGenesis

Sex: All·Age: 18+

Code: NCT06014502·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.

for Advanced Solid Tumors

5 locations incl. Scottsdale

Sponsor: Sun Pharma Advanced Research Company Limited

Sex: All·Age: 18+

Code: NCT07042100·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

for Solid Tumours

3 locations incl. Beverly Hills

Sponsor: Epkin

Sex: All·Age: 18+

Code: NCT06789172·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors

for Muscle-Invasive Bladder Carcinoma

1 location in Santa Monica

Sponsor: Vasgene Therapeutics, Inc

Sex: All·Age: 18+

Code: NCT06493552·Phase 2, Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer

for Breast Cancer

1 location in Santa Monica

Sponsor: BriaCell Therapeutics Corporation

Sex: All·Age: 18+

Code: NCT06471673·Phase 1, Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

Metastatic Leiomyosarcoma Biomarker Protocol

for Leiomyosarcoma

9 locations incl. Santa Monica

Sponsor: University of Michigan Rogel Cancer Center

Sex: All·Age: All ages

Code: NCT05653388·Recruiting·Listed Dec 2022

Apply to this trial

SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma

for Advanced Soft Tissue Sarcoma

1 location in Santa Monica

Sponsor: Sarcoma Oncology Research Center, LLC

Sex: All·Age: 18+

Code: NCT03138161·Phase 1, Phase 2·Recruiting·Listed May 2017

Apply to this trial

Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma

for Sarcoma

1 location in Santa Monica

Sponsor: Sarcoma Oncology Research Center, LLC

Sex: All·Age: 18+

Code: NCT03886311·Phase 2·Recruiting·Listed Mar 2019

Apply to this trial

Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma

for Leiomyosarcoma

1 location in Santa Monica

Sponsor: Sarcoma Oncology Research Center, LLC

Sex: All·Age: 18+

Code: NCT04535271·Phase 2·Recruiting·Listed Sep 2020

Apply to this trial

GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma

for Sarcoma

1 location in Santa Monica

Sponsor: Sarcoma Oncology Research Center, LLC

Sex: All·Age: 18+

Code: NCT04535713·Phase 2·Recruiting·Listed Sep 2020

Apply to this trial

LINNOVATE: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue Sarcoma

for Advanced Soft-tissue Sarcoma

1 location in Santa Monica

Sponsor: ERLINDA M GORDON

Sex: All·Age: 18 - 90

Code: NCT05876715·Phase 1, Phase 2·Recruiting·Listed May 2023

Apply to this trial

More research sites in Santa Monica

Sarcoma Oncology Center (10 trials)
UCLA (10 trials)
UCLA Hematology/Oncology - Santa Monica (9 trials)
Saint John's Cancer Institute (7 trials)
Source Healthcare (7 trials)
Sarcoma Oncology Research Center (5 trials)
UCLA Santa Monica Medical Center (5 trials)
Citruslabs (4 trials)
University of California Los Angeles (4 trials)
Providence Saint John's Health Center (4 trials)

Explore more

Paid clinical trials in Santa Monica, CA · California clinical trials